首页> 美国卫生研究院文献>Journal of the Boston Society of Medical Sciences >Endogenous Proteolytic Cleavage of Normal and Disease-Associated Isoforms of the Human Prion Protein in Neural and Non-Neural Tissues
【2h】

Endogenous Proteolytic Cleavage of Normal and Disease-Associated Isoforms of the Human Prion Protein in Neural and Non-Neural Tissues

机译:神经和非神经组织中人Pri蛋白的正常和疾病相关同工型的内源性蛋白水解切割。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

We have investigated the proteolytic cleavage of the cellular (PrPC) and pathological (PrPSc) isoforms of the human prion protein (PrP) in normal and prion-affected brains and in tonsils and platelets from neurologically intact individuals. The various PrP species were resolved after deglycosylation according to their electrophoretic mobility, immunoreactivity, Sarkosyl solubility, and, as a novel approach, resistance to endogenous proteases. First, our data show that PrPC proteolysis in brain originates amino-truncated peptides of 21 to 22 and 18 (C1) kd that are similar in different regions and are not modified by the PrP codon 129 genotype, a polymorphism that affects the expression of prion disorders. Second, this proteolytic cleavage of PrPC in brain is blocked by inhibitors of metalloproteases. Third, differences in PrPC proteolysis, and probably in Asn glycosylation and glycosylphosphatidylinositol anchor composition, exist between neural and non-neural tissues. Fourth, protease-resistant PrPSc cores in sporadic Creutzfeldt-Jakob disease (CJD) and Gerstmann-Sträussler-Scheinker F198S disease brains all have an intact C1 cleavage site (Met111-His112), which precludes disruption of a domain associated with toxicity and fibrillogenesis. Fifth, the profile of endogenous proteolytic PrPSc peptides is characteristic of each disorder studied, thus permitting the molecular classification of these prion diseases without the use of proteinase K and even a recognition of PrPSc heterogeneity within type 2 CJD patients having different codon 129 genotype and neuropathological phenotype. This does not exclude the role of additional factors in phenotypic expression; in particular, differences in glycosylation that may be especially relevant in the new variant CJD. Proteolytic processing of PrP may play an important role in the neurotropism and phenotypic expression of prion diseases, but it does not appear to participate in disease susceptibility.
机译:我们研究了正常和受pr病毒感染的人大脑中病毒蛋白(PrP)的细胞(PrP C )和病理性(PrP Sc )同工型的蛋白水解切割,神经完整的扁桃体和血小板中的蛋白各种PrP物种根据其电泳迁移率,免疫反应性,Sarkosyl溶解度以及作为一种新方法对内源蛋白酶的抗性,在去糖基化后得到分离。首先,我们的数据表明,PrP C 在大脑中的蛋白水解作用是产生21至22和18(C1)kd的氨基酸截短肽,在不同区域相似,并且未被PrP密码子129基因型修饰,影响of病毒疾病表达的多态性。第二,PrP C 在脑中的这种蛋白水解切割被金属蛋白酶抑制剂阻断。第三,在神经组织和非神经组织之间存在PrP C 蛋白水解的差异,并且可能存在Asn糖基化和糖基磷脂酰肌醇固定蛋白的差异。第四,散发性Creutzfeldt-Jakob病(CJD)和Gerstmann-Sträussler-ScheinkerF198S疾病大脑中的蛋白酶抗性PrP Sc 核心均具有完整的C1裂解位点(Met111-His112),因此无法破坏与毒性和原纤维形成相关的域。第五,内源蛋白水解的PrP Sc 肽的概况是每种研究疾病的特征,因此可以在不使用蛋白酶K甚至识别PrP Sc <的情况下对这些病毒疾病进行分子分类。在具有不同密码子129基因型和神经病理学表型的2型CJD患者中存在异质性。这并不排除其他因素在表型表达中的作用。特别是在新的CJD变体中可能特别相关的糖基化差异。 PrP的蛋白水解过程可能在病毒疾病的神经向性和表型表达中起重要作用,但似乎不参与疾病易感性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号